{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:21:43Z","timestamp":1776216103054,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U54 NS079202"],"award-info":[{"award-number":["U54 NS079202"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01 NS112102"],"award-info":[{"award-number":["U01 NS112102"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s13311-020-00985-5","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T11:34:24Z","timestamp":1609932864000},"page":"544-555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Intranasal Allopregnanolone Confers Rapid Seizure Protection: Evidence for Direct Nose-to-Brain Delivery"],"prefix":"10.1016","volume":"18","author":[{"given":"Dorota","family":"Zolkowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3296-8193","authenticated-orcid":false,"given":"Michael A.","family":"Rogawski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-020-00985-5_bib1","doi-asserted-by":"crossref","unstructured":"Allen DB. Systemic effects of intranasal steroids: an endocrinologist's perspective. J Allergy Clin Immunol. 2000 Oct;106(4 Suppl):S179-90.","DOI":"10.1067\/mai.2000.110038"},{"issue":"6","key":"10.1007\/s13311-020-00985-5_bib2","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1046\/j.1460-9568.1998.00223.x","article-title":"Mapping of neuronal networks underlying generalized seizures induced by increasing doses of pentylenetetrazol in the immature and adult rat: a c-Fos immunohistochemical study","volume":"10","author":"Andr\u00e9","year":"1998","journal-title":"Eur J Neurosci."},{"issue":"3","key":"10.1007\/s13311-020-00985-5_bib3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF00237470","article-title":"Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat","volume":"63","author":"Baker","year":"1986","journal-title":"Exp Brain Res."},{"issue":"11","key":"10.1007\/s13311-020-00985-5_bib4","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/epi.13131","article-title":"Pharmacokinetics, pharmacodyna,mics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers","volume":"56","author":"Bancke","year":"2015","journal-title":"Epilepsia."},{"issue":"2","key":"10.1007\/s13311-020-00985-5_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/10611860802382777","article-title":"Delivery of testosterone to the brain by intranasal administration: comparison to intravenous testosterone","volume":"17","author":"Banks","year":"2009","journal-title":"J Drug Target."},{"issue":"2","key":"10.1007\/s13311-020-00985-5_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0014-2999(89)90077-0","article-title":"Anticonvulsant profile of the progesterone metabolite 5\u03b1-pregnan-3\u03b1-ol-20-one","volume":"166","author":"Belelli","year":"1989","journal-title":"Eur J Pharmacol."},{"issue":"4","key":"10.1007\/s13311-020-00985-5_bib7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1528-1167.2006.00502.x","article-title":"Imaging the neural substrates involved in the genesis of pentylenetetrazol-induced seizures","volume":"47","author":"Brevard","year":"2006","journal-title":"Epilepsia."},{"issue":"1","key":"10.1007\/s13311-020-00985-5_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0015-0282(16)54433-1","article-title":"Progesterone administration by nasal spray","volume":"56","author":"Cicinelli","year":"1991","journal-title":"Fertil Steril."},{"key":"10.1007\/s13311-020-00985-5_bib9","doi-asserted-by":"crossref","unstructured":"Costantino HR, Illum L, Brandt G, Johnson PH, Quay SC. Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm. 2007 Jun 7;337(1-2):1-24.","DOI":"10.1016\/j.ijpharm.2007.03.025"},{"key":"10.1007\/s13311-020-00985-5_bib10","doi-asserted-by":"crossref","unstructured":"Davis SS, Illum L. Absorption enhancers for nasal drug delivery. Clin Pharmacokinet. 2003;42(13):1107-28.","DOI":"10.2165\/00003088-200342130-00003"},{"key":"10.1007\/s13311-020-00985-5_bib11","doi-asserted-by":"crossref","unstructured":"Del Pizzo J, Callahan JM. Intranasal medications in pediatric emergency medicine. Pediatr Emerg Care. 2014 Jul;30(7):496-501; quiz 502-4. https:\/\/doi.org\/10.1097\/PEC.0000000000000171.","DOI":"10.1097\/PEC.0000000000000171"},{"issue":"1","key":"10.1007\/s13311-020-00985-5_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuroscience.2008.09.003","article-title":"Intranasal administration of progesterone increases dopaminergic activity in amygdala and neostriatum of male rats","volume":"157","author":"de Souza Silva","year":"2008","journal-title":"Neuroscience."},{"issue":"1","key":"10.1007\/s13311-020-00985-5_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.euroneuro.2008.08.003","article-title":"Dopaminergic and serotonergic activity in neostriatum and nucleus accumbens enhanced by intranasal administration of testosterone","volume":"19","author":"de Souza Silva","year":"2009","journal-title":"Eur Neuropsychopharmacol."},{"key":"10.1007\/s13311-020-00985-5_bib14","doi-asserted-by":"crossref","unstructured":"Dhuria SV, Hanson LR, Frey WH 2nd. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci. 2010 Apr;99(4):1654-73. https:\/\/doi.org\/10.1002\/jps.21924.","DOI":"10.1002\/jps.21924"},{"issue":"2","key":"10.1007\/s13311-020-00985-5_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0304-3940(87)90121-2","article-title":"Generalized seizures induce c-fos protein(s) in mammalian neurons","volume":"82","author":"Dragunow","year":"1987","journal-title":"Neurosci Lett."},{"key":"10.1007\/s13311-020-00985-5_bib16","doi-asserted-by":"crossref","unstructured":"Ducharme N, Banks WA, Morley JE, Robinson SM, Niehoff ML, Mattern C, Farr SA. Brain distribution and behavioral effects of progesterone and pregnenolone after intranasal or intravenous administration. Eur J Pharmacol. 2010 Sep 1;641(2-3):128-34. https:\/\/doi.org\/10.1016\/j.ejphar.2010.05.033.","DOI":"10.1016\/j.ejphar.2010.05.033"},{"key":"10.1007\/s13311-020-00985-5_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/10717549709051878","article-title":"Delivery of 125I-NGF to the brain via the olfactory route","volume":"4","author":"Frey","year":"1997","journal-title":"Drug Delivery."},{"key":"10.1007\/s13311-020-00985-5_bib18","doi-asserted-by":"crossref","unstructured":"G\u00e4nger S, Schindowski K. Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa. Pharmaceutics. 2018 Aug 3;10(3). https:\/\/doi.org\/10.3390\/pharmaceutics10030116.","DOI":"10.3390\/pharmaceutics10030116"},{"key":"10.1007\/s13311-020-00985-5_bib19","doi-asserted-by":"crossref","unstructured":"Graff CL, Pollack GM. Nasal drug administration: potential for targeted central nervous system delivery. J Pharm Sci. 2005 Jun;94(6):1187-95.","DOI":"10.1002\/jps.20318"},{"key":"10.1007\/s13311-020-00985-5_bib20","doi-asserted-by":"crossref","unstructured":"Grassin-Delyle S, Buenestado A, Naline E, Faisy C, Blouquit-Laye S, Couderc LJ, Le Guen M, Fischler M, Devillier P. Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. Pharmacol Ther. 2012 Jun;134(3):366-79. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.03.003.","DOI":"10.1016\/j.pharmthera.2012.03.003"},{"issue":"12","key":"10.1007\/s13311-020-00985-5_bib21","first-page":"963","article-title":"Intranasal administration of midazolam in a cyclodextrin based formulation: bioavailability and clinical evaluation in humans","volume":"56","author":"Gudmundsdottir","year":"2001","journal-title":"Pharmazie."},{"issue":"1","key":"10.1007\/s13311-020-00985-5_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymthe.2006.02.018","article-title":"The \u2018perivascular pump' driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain","volume":"14","author":"Hadaczek","year":"2006","journal-title":"Mol Ther"},{"key":"10.1007\/s13311-020-00985-5_bib23","doi-asserted-by":"crossref","unstructured":"Hanson LR, Fine JM, Svitak AL, Faltesek KA. Intranasal administration of CNS therapeutics to awake mice. J Vis Exp. 2013;(74):4440. https:\/\/doi.org\/10.3791\/4440.","DOI":"10.3791\/4440-v"},{"key":"10.1007\/s13311-020-00985-5_bib24","doi-asserted-by":"crossref","unstructured":"Hintiryan H, Gou L, Zingg B, Yamashita S, Lyden HM, Song MY, Grewal AK, Zhang X, Toga AW, Dong HW. Comprehensive connectivity of the mouse main olfactory bulb:analysis and online digital atlas. Front Neuroanat. 2012 Aug 7;6:30. https:\/\/doi.org\/10.3389\/fnana.2012.00030.","DOI":"10.3389\/fnana.2012.00030"},{"issue":"3","key":"10.1007\/s13311-020-00985-5_bib25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/epi.16449","article-title":"Bioavailability and safety of diazepam intranasal solution compared to oral and rectal diazepam in healthy volunteers","volume":"61","author":"Hogan","year":"2020","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-020-00985-5_bib26","doi-asserted-by":"crossref","unstructured":"Illum L. Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci. 2000 Jul;11(1):1-18.","DOI":"10.1016\/S0928-0987(00)00087-7"},{"issue":"1","key":"10.1007\/s13311-020-00985-5_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1211\/0022357022539","article-title":"Is nose-to-brain transport of drugs in man a reality?","volume":"56","author":"Illum","year":"2004","journal-title":"J Pharm Pharmacol."},{"issue":"5","key":"10.1007\/s13311-020-00985-5_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11095-019-2613-8","article-title":"Direct drug delivery of low-permeable compounds to the central nervous system via intranasal administration in rats and monkeys","volume":"36","author":"Iwasaki","year":"2019","journal-title":"Pharm Res."},{"key":"10.1007\/s13311-020-00985-5_bib29","doi-asserted-by":"crossref","unstructured":"Kadohisa M. Effects of odor on emotion, with implications. Front Syst Neurosci. 2013 Oct 10;7:66. https:\/\/doi.org\/10.3389\/fnsys.2013.00066.","DOI":"10.3389\/fnsys.2013.00066"},{"key":"10.1007\/s13311-020-00985-5_bib30","doi-asserted-by":"crossref","unstructured":"K\u00e4lvi\u00e4inen R. Intranasal therapies for acute seizures. Epilepsy Behav. 2015 Aug;49:303-6. https:\/\/doi.org\/10.1016\/j.yebeh.2015.04.027.","DOI":"10.1016\/j.yebeh.2015.04.027"},{"key":"10.1007\/s13311-020-00985-5_bib31","doi-asserted-by":"crossref","unstructured":"Kapoor M, Cloyd JC, Siegel RA. A review of intranasal formulations for the treatment of seizure emergencies. J Control Release. 2016 Sep 10;237:147-59. https:\/\/doi.org\/10.1016\/j.jconrel.2016.07.001.","DOI":"10.1016\/j.jconrel.2016.07.001"},{"issue":"1","key":"10.1007\/s13311-020-00985-5_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijpharm.2008.07.030","article-title":"Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits","volume":"364","author":"Kaur","year":"2008","journal-title":"Int J Pharm."},{"issue":"3","key":"10.1007\/s13311-020-00985-5_bib33","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0022-3565(25)22531-9","article-title":"Anticonvulsant activity of neurosteroids: correlation with \u03b3-aminobutyric acid-evoked chloride current potentiation","volume":"270","author":"Kokate","year":"1994","journal-title":"J Pharmacol Exp Ther."},{"issue":"1","key":"10.1007\/s13311-020-00985-5_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/10717544.2013.840017","article-title":"Manipulation of olfactory tight junctions using papaverine to enhance intranasal delivery of gemcitabine to the brain","volume":"21","author":"Krishan","year":"2014","journal-title":"Drug Deliv"},{"issue":"1","key":"10.1007\/s13311-020-00985-5_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3233\/ADR-170033","article-title":"Alzheimer's disease and intranasal fluticasone propionate in the FDA MedWatch adverse events database","volume":"2","author":"Lehrer","year":"2018","journal-title":"J Alzheimers Dis Rep."},{"issue":"11","key":"10.1007\/s13311-020-00985-5_bib36","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3390\/pharmaceutics11110598","article-title":"Perivascular and perineural pathways involved in brain delivery and distribution of drugs after intranasal administration","volume":"11","author":"Lochhead","year":"2019","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1007\/s13311-020-00985-5_bib37","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv Drug Deliv Rev."},{"issue":"3","key":"10.1007\/s13311-020-00985-5_bib38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/jcbfm.2014.215","article-title":"Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration","volume":"35","author":"Lochhead","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1007\/s13311-020-00985-5_bib39","doi-asserted-by":"crossref","unstructured":"Lumry WR. A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis. J Allergy Clin Immunol. 1999 Oct;104(4 Pt 1):S150-8.","DOI":"10.1016\/S0091-6749(99)70311-8"},{"issue":"8","key":"10.1007\/s13311-020-00985-5_bib40","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1021\/acs.jmedchem.5b00032","article-title":"Neuroactive Steroids. 1. Positive allosteric modulators of the (\u03b3-Aminobutyric Acid)A receptor: structure-activity relationships of heterocyclic substitution at C-21","volume":"58","author":"Martinez Botella","year":"2015","journal-title":"J Med Chem."},{"key":"10.1007\/s13311-020-00985-5_bib41","doi-asserted-by":"crossref","unstructured":"Marttin E, Verhoef JC, Merkus FW. Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs. J Drug Target. 1998;6(1):17-36.","DOI":"10.3109\/10611869808997878"},{"key":"10.1007\/s13311-020-00985-5_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuroscience.2012.11.039","article-title":"Distribution of membrane progesterone receptor alpha in the male mouse and rat brain and its regulation after traumatic brain injury","volume":"231","author":"Meffre","year":"2013","journal-title":"Neuroscience."},{"issue":"2","key":"10.1007\/s13311-020-00985-5_bib43","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1124\/jpet.107.132381","article-title":"Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins","volume":"325","author":"Nonaka","year":"2008","journal-title":"J Pharmacol Exp Ther."},{"issue":"6","key":"10.1007\/s13311-020-00985-5_bib44","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1152\/jn.2001.86.6.2823","article-title":"Disruption of GABAA receptors on GABAergic interneurons leads to increased oscillatory power in the olfactory bulb network","volume":"86","author":"Nusser","year":"2001","journal-title":"J Neurophysiol."},{"issue":"1","key":"10.1007\/s13311-020-00985-5_bib45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1172\/JCI109433","article-title":"Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone","volume":"64","author":"Pardridge","year":"1979","journal-title":"J Clin Invest."},{"issue":"2","key":"10.1007\/s13311-020-00985-5_bib46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1060028019873320","article-title":"Brexanolone (Zulresso): Finally, an FDA-approved treatment for postpartum depression","volume":"54","author":"Powell","year":"2020","journal-title":"Ann Pharmacother."},{"key":"10.1007\/s13311-020-00985-5_bib47","series-title":"Jasper's Basic Mechanisms of the Epilepsies [Internet]","article-title":"Neurosteroids \u2014 endogenous regulators of seizure susceptibility and role in the treatment of epilepsy","author":"Reddy","year":"2012"},{"key":"10.1007\/s13311-020-00985-5_bib48","doi-asserted-by":"crossref","unstructured":"Rogawski MA, Loya CM, Reddy K, Zolkowska D, Lossin C. Neuroactive steroids for the treatment of status epilepticus. Epilepsia. 2013 Sep;54 Suppl 6:93-8. https:\/\/doi.org\/10.1111\/epi.12289.","DOI":"10.1111\/epi.12289"},{"key":"10.1007\/s13311-020-00985-5_bib49","unstructured":"Rogawski MA, Zolkowska D. Anticonvulsant activity of steroids, U.S. Patent 10,251,894 issued April 9, 2019."},{"key":"10.1007\/s13311-020-00985-5_bib50","unstructured":"Scarff JR. Use of brexanolone for postpartum depression. Innov Clin Neurosci. 2019 Nov 1;16(11-12):32-35."},{"issue":"3","key":"10.1007\/s13311-020-00985-5_bib51","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.pbb.2009.10.003","article-title":"Allopregnanolone, the active metabolite of progesterone protects against neuronal damage in picrotoxin-induced seizure model in mice","volume":"94","author":"Singh","year":"2010","journal-title":"Pharmacol Biochem Behav."},{"key":"10.1007\/s13311-020-00985-5_bib52","doi-asserted-by":"crossref","unstructured":"Tanimoto S, Pesco Koplowitz L, Lowenthal RE, Koplowitz B, Rabinowicz AL, Carrazana E. Evaluation of pharmacokinetics and dose proportionality of diazepam after intranasal administration of NRL-1 to healthy volunteers. Clin Pharmacol Drug Dev. 2020 Jan 9. https:\/\/doi.org\/10.1002\/cpdd.767.","DOI":"10.1002\/cpdd.767"},{"issue":"3","key":"10.1007\/s13311-020-00985-5_bib53","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00213-005-0148-7","article-title":"Pharmacokinetic and behavioral effects of allopregnanolone in healthy women","volume":"186","author":"Timby","year":"2006","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1007\/s13311-020-00985-5_bib54","unstructured":"U.S. Food and Drug Administration. NAYZILAM\u00ae (midazolam) nasal spray CIV US Prescribing Information. 2019:1\u201323. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/211321s000lbl.pd"},{"issue":"6","key":"10.1007\/s13311-020-00985-5_bib55","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/acn3.408","article-title":"First-in-man allopregnanolone use in super-refractory status epilepticus","volume":"4","author":"Vaitkevicius","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1007\/s13311-020-00985-5_bib56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejpb.2004.02.010","article-title":"Uptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in rats","volume":"58","author":"van den Berg","year":"2004","journal-title":"Eur J Pharm Biopharm."},{"issue":"1","key":"10.1007\/s13311-020-00985-5_bib57","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijpharm.2006.02.055","article-title":"Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method","volume":"317","author":"Wang","year":"2006","journal-title":"Int J Pharm."},{"issue":"3","key":"10.1007\/s13311-020-00985-5_bib58","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1124\/jpet.119.258152","article-title":"Nose-to-Brain delivery","volume":"370","author":"Wang","year":"2019","journal-title":"J Pharmacol Exp Ther."},{"issue":"4","key":"10.1007\/s13311-020-00985-5_bib59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jsmc.2010.08.003","article-title":"Neuropharmacology of sleep and wakefulness","volume":"5","author":"Watson","year":"2010","journal-title":"Sleep Med Clin"},{"issue":"2-3","key":"10.1007\/s13311-020-00985-5_bib60","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eplepsyres.2008.10.005","article-title":"A pharmacokinetic and pharmacodynamic study, in healthy volunteers, of a rapidly absorbed intranasal midazolam formulation","volume":"83","author":"Wermeling","year":"2009","journal-title":"Epilepsy Res."},{"issue":"8","key":"10.1007\/s13311-020-00985-5_bib61","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/01616412.2019.1610839","article-title":"C-Fos mapping and EEG characteristics of multiple mice brain regions in pentylenetetrazol-induced seizure mice model","volume":"41","author":"Yang","year":"2019","journal-title":"Neurol Res."},{"issue":"4","key":"10.1007\/s13311-020-00985-5_bib62","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.yhbeh.2011.01.007","article-title":"Intranasal administration of testosterone increased immobile-sniffing, exploratory behavior, motor behavior and grooming behavior in rats","volume":"59","author":"Zhang","year":"2011","journal-title":"Horm Behav."},{"issue":"Suppl 2","key":"10.1007\/s13311-020-00985-5_bib63","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/epi.13999","article-title":"Intramuscular allopregnanolone and ganaxolone in a mouse model of treatment-resistant status epilepticus","volume":"59","author":"Zolkowska","year":"2018","journal-title":"Epilepsia."}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00985-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-020-00985-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923012151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923012151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00985-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:58:00Z","timestamp":1761807480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923012151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1878747923012151"],"URL":"https:\/\/doi.org\/10.1007\/s13311-020-00985-5","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal Allopregnanolone Confers Rapid Seizure Protection: Evidence for Direct Nose-to-Brain Delivery","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-020-00985-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The authors. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}